Literature DB >> 29434010

National Prevalence of Self-Reported Coronary Heart Disease and Chronic Stable Angina Pectoris: Factor Analysis of the Underlying Cardiometabolic Risk Factors in the SuRFNCD-2011.

Mehrshad Abbasi1, Mohamadreza Neishaboury2, Jalil Koohpayehzadeh3, Koorosh Etemad3, Alipasha Meysamie4, Fereshteh Asgari3, Sina Noshad2, Mohsen Afarideh5, Alireza Ghajar2, Morsaleh Ganji2, Ali Rafei3, Mostafa Mousavizadeh2, Elias Khajeh2, Behnam Heidari2, Mohammad Saadat5, Manouchehr Nakhjavani2, Alireza Esteghamati6.   

Abstract

BACKGROUND: Coronary heart disease (CHD) is one of the most common causes of mortality worldwide. The national prevalence remains unclear in most of the developing countries.
OBJECTIVE: This study sought to estimate national prevalence of self-reported CHD and chronic stable angina pectoris in the general adult population of Iran using data from the fourth round of the Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2011) survey.
METHODS: The analysis comprised data of 11,867 civilian, nonhospitalized and noninstitutionalized residents ages 6 to 70 years of age. The calculated prevalence of self-reported CHD and chronic stable angina pectoris were extrapolated to the Iranian adult population who were >20 years old using the complex sample analysis. The factor analysis was performed for clustering of the associated cardiometabolic risk factors among people ages >40 years of age.
RESULTS: The estimated national prevalence of self-reported CHD and chronic stable angina pectoris were 5.3% (95% confidence interval: 4.6 to 5.9) and 7.7% (95% confidence interval: 4.6 to 8.7), respectively. Higher prevalence of these conditions were observed among the older people, urban residents, and women. Factor analysis generated 4 distinct factors that were mainly indicators of dyslipidemia, hypertension, central obesity, hyperglycemia, and tobacco smoking. The factor incorporating hypertension was a significant correlate of self-reported CHD.
CONCLUSIONS: We report concerning prevalence of self-reported CHD and chronic stable angina pectoris in the adult population of Iran. The constellation of raised systolic and diastolic blood pressures was significantly predictive of the presence of self-reported CHD.
Copyright © 2018 World Heart Federation (Geneva). Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29434010     DOI: 10.1016/j.gheart.2018.01.001

Source DB:  PubMed          Journal:  Glob Heart


  5 in total

1.  The prevalence and predictors of cardiovascular diseases in Kherameh cohort study: a population-based study on 10,663 people in southern Iran.

Authors:  Najibullah Baeradeh; Masoumeh Ghoddusi Johari; Leila Moftakhar; Ramin Rezaeianzadeh; Seyed Vahid Hosseini; Abbas Rezaianzadeh
Journal:  BMC Cardiovasc Disord       Date:  2022-05-28       Impact factor: 2.174

2.  Prevalence and Correlates of Self-Reported Cardiovascular Diseases Among a Nationally Representative Population-Based Sample of Adults in Ecuador in 2018.

Authors:  Supa Pengpid; Karl Peltzer
Journal:  Vasc Health Risk Manag       Date:  2021-05-04

3.  Health-related quality of life and associated factors in patients with myocardial infarction after returning to work: a cross-sectional study.

Authors:  Ruofei Du; Panpan Wang; Lixia Ma; Leon M Larcher; Tao Wang; Changying Chen
Journal:  Health Qual Life Outcomes       Date:  2020-06-17       Impact factor: 3.186

4.  Prevalence of self-reported coronary heart disease and its associated risk factors in Tabari cohort population.

Authors:  Ali Ghaemian; Maryam Nabati; Majid Saeedi; Motahareh Kheradmand; Mahmood Moosazadeh
Journal:  BMC Cardiovasc Disord       Date:  2020-05-19       Impact factor: 2.298

5.  Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008-2011.

Authors:  Seyyed Saeed Moazzeni; Hamidreza Ghafelehbashi; Mitra Hasheminia; Donna Parizadeh; Arash Ghanbarian; Fereidoun Azizi; Farzad Hadaegh
Journal:  BMC Public Health       Date:  2020-10-06       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.